NSA PHARMA LIMITED
Significant control: Samuel Osunsanya (25–50%), Akindayo Habeeb Adegbesan (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nsa Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Nsa Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NSA PHARMA LIMITED is an active private limited company (company number 09315791) incorporated on 18 November 2014, registered in Romford. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 30 November 2025, showing net assets of −£35k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 7% on the prior period (−£33k). Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the bottom quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).
Ownership and control
- Mr Samuel Osunsanya
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Akindayo Habeeb Adegbesan
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Nickesh Ravindra Gadhvi
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 18 November 201411 yrs ago
- Next accounts due
- 30 August 2027in 310 days
- Confirmation statement due
- 2 December 2026in 39 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£35k | — | — | — | — | — | 1 |
| 30 November 2024 | −£33k | — | — | — | — | — | 1 |
| 30 November 2023 | −£37k | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-34,901 at 30 November 2025
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 18 November 2014
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 310 days
- Confirmation statement duein 39 days
- Accounts period endNet liabilities £35k · micro accounts
- Accounts period endNet liabilities £33k · micro accounts
- Accounts period endNet liabilities £37k · micro accounts
- Incorporated
Similar companies in Greater London
- OZONE MEDICAL SUPPLIES LTDWembley · inc. Nov 2014
- ROVI BIOTECH LIMITEDBromley · inc. Dec 2014
- MEDICURE SCIENTIFIC LIMITEDIlford · inc. Oct 2014
- HALEON UK TRADING LIMITEDWeybridge · inc. Sept 2014
- GJB PHARMA LIMITEDBorehamwood · inc. Sept 2014
- LONDON HEALTH SUPPLIERS LIMITEDCroydon · inc. Jan 2015
All companies incorporated on 18 November 2014 · in Nov 2014.
Reminders for NSA PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.